This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.


Times are in Pacific Daylight Time (PDT)/Vancouver, BC Time.

Saturday, October 15, 2022

  • 08:00 09:45

    Session I: Introduction to AUD/ALD: Epidemiology and Pathophysiology

    The Learning Objectives are:

    • Summarize the impact of alcohol use on patients living with NAFLD
    • Describe the effect of alcohol consumption on patients living with HCV
    • Understand the "disease model" of addiction    
    • Understand the potential for pharmacotherapy in treating addiction

    Moderator: Mayur Brahmania, Calgary, AB

    8:05 - 8:25: Epidemiology of Alcohol Use Disorder and Alcohol-Associated Liver Disease in Canada, Jennifer Flemming, Queen's University, Kingston, ON

    8:25 - 8:45: Comorbid Liver Disease: Alcohol Use in NASH and HCV, Stephen Congly, University of Calgary, Calgary, AB

    8:45 - 9:05: Pathophysiology of Alcohol-Associated Liver Disease and Targets for Alcohol-Associated Hepatitis Treatments, Brian Lee, University of Southern California, Los Angeles, CA, USA

    9:05 - 9:25: Neurobiology of Addictions, Milan Khara, University of British Columbia, Vancouver, BC

    9:25 - 9:45: Panel Discussion/Q&A

  • 09:45 10:05

    AM Break & Exhibits

  • 10:05 12:05

    Session II: Early ALD: Screening, Linkage to care, Integrated care models

    The Learning Objectives are:

    • Describe alcohol-related screening tools and biomarkers relevant to hepatology
    • Expand attendees expertise in using of these tools with their patients

    Moderator: Puneeta Tandon, Edmonton, AB

    10:05 - 10:25: Screening Tools and Biomarkers for AUD, Scott Winder, University of Michigan, Ann Arbor, MI, USA

    10:25 - 10:45: Referral Pathways for ALD, Abdel-Aziz Shaheen, University of Calgary, AB

    10:45 - 11:05: Pharmacological Therapy for AUD, Considerations for ALD, Doug Simonetto, Mayo Clinic, Rochester, MN, USA

    11:05 - 11:45: Integrated Care Model: Multidisciplinary Clinic for Management of ALD, Lisa Bromley, The Ottawa Hospital, ON, Nabiha Faisal, University of Manitoba, MB, Cassidy Parker, Calgary, AB, Milan Khara, University of British Columbia, Vancouver, BC, Brian Lee, University of Southern California, Los Angeles, CA 

    11:45 - 12:05: Panel Discussion / Q&A

  • 12:05 13:05

    Lunch Break

  • 13:05 14:25

    Session III: Communication Strategies and Motivational Interviewing for individuals with AUD and ALD

    The Learning Objectives are:

    • Review basic principles of Motivational Interviewing    
    • Understand the benefits of an integrated GI/ Addiction Medicine clinic for ALD
    • Review and identify key motivation interviewing principles
    • Practice MI techniques that are useful in clinical settings

    Moderator: Lisa Bromley, Ottawa, ON

    13:05 - 13:25: Alcohol Brief Intervention: Communication Strategies with People Who Use Alcohol, Elizabeth Lee, University Health Network- Toronto General Hospital, ON

    13:25 - 14:25: Motivational Interviewing, Erin Knight, University Of Manitoba, MB

  • 14:25 14:45

    PM Break & Exhibits

  • 14:45 16:30

    Session IV: Advanced ALD: Therapeutics, Considerations around Liver Transplantation

    The Learning Objectives are:

    • Describe the psychosocial evaluation process for liver transplant candidacy in patients with alcohol-associated liver disease
    • List positive and negative prognostic factors for relapse to harmful alcohol use post transplantation
    • Explore the important aspects of a psychosocial evaluation for transplant suitability for ALD patients
    • Explain various options for psychosocial treatment/support to bolster transplant suitability and decrease risk for relapse

    Moderators: Cynthia Tsien, Toronto, ON

    14:45 - 14:50: Case Study: ALD and Liver Transplant, Cynthia Tsien, Ajmera Transplant Centre, University Health Network, Toronto, ON 

    14:50 - 15:30: Case Discussion: Management of the Hospitalized Patient with ALD, Alcohol-Associated Hepatitis Treatment/Therapeutics, When to Consider Transplant, Lauren Carrique, University Health Network, Toronto, ON, Phil Wong, McGill University, Montreal, QC, Saumya Jayakumar, Vancouver, BC, Meredith Borman, Calgary, AB

    15:30 - 15:50: Recommendations for Psychosocial Evaluation of Transplant Candidate, Josee Lynch, University Health Network/University of Toronto, Toronto, ON

    15:50 - 16:10: Defining Success After Transplant for ALD: Relapses, Slips, Prognostic Factors, Nazia Selzner, University Health Network/University of Toronto, Toronto, ON

    16:10 - 16:30: Panel Discussion / Q&A

  • 16:30 18:00

    Reception & Trainee Debate

    The Learning Objectives are:

    • Review the evidence-based treatment options for alcohol-use disorder
    • Explain the role of hepatologists in managing alcohol-use disorder in patients with alcohol-related liver disease

    16:30 - 17:15: Trainee Debate - PRO or CON: Alcohol use disorder in patients with cirrhosis should be managed primarily by hepatologists, PRO: Jordan Francheville, QEII-Halifax vs. CON: Ben Cox, Ajmera Transplant Centre, University Health Network, Toronto, ON,

    Moderator David Wong, Toronto, ON

    17:15 - 17:30: Q&A